GFO Issue 51, Article Number: 4

Share:

ROUND FIVE DECISIONS

N/A
Article Type: News Author: Bernard Rivers Date: 2005-10-03
ABSTRACT

ABSTRACT A detailed listing and analysis is provided of which Round 5 proposals have been approved.

Based on advise from the Technical Review Panel (TRP), the Board divides eligible proposals into five Categories, as follows:

  • Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 4 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
  • Category 2A: Proposals that are provisionally approved subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to respond to the TRP queries, 4 months to obtain the final TRP approval should further clarifications be requested). The primary reviewer and secondary reviewer as well as TRP Chair and /or Vice-Chair need to give final approval.
  • Category 2B: Similar to Category 2A, but regarded as relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation. The TRP took no account of the applicant country's income level, nor of burden of disease nor of any factors other than technical merit and feasibility in grading a proposal as Category 2B. In other words, these proposals differ from Category 2A proposals only in that they have more technical weaknesses, and/or more questions as to effective implementation, and/or more required clarifications. It is important to note, however, that on balance all of the Category 2B proposals were regarded as recommended for funding, and the TRP believes that the weaknesses and clarifications could be addressed within the timeframes provided for Category 2A proposals.
  • Category 3: Not approved in their present form, but applicants are encouraged to submit an improved proposal in some future Round.
  • Category 4: Rejected.
If the Fund had sufficient pledges for 2005 to cover the cost of all Category 1, 2A and 2B proposals, it would have approved all of them at last week's meeting, subject to the applicants responding acceptably to the TRP's requests for clarification that will be sent to the applicants.

However, given that the Fund currently has insufficient pledges to cover all the Category 1, 2A and 2B proposals, the board agreed to proceed as follows, using a procedure specified at an earlier board meeting:

  • Category 1 proposals are approved.
  • Category 2A and 2B proposals are given a "Composite Index" of between 1 and 8 points, as follows:
  • If the country has a "very high" disease burden, it receives 4 points, and otherwise it receives 1 point.
  • In addition, if the country is "low-income" it receives 4 points, and if it is "lower-middle income" it receives 2 points. ("Upper-middle income" countries receive 0 extra points.)
Proposals were ranked by Category and then, for Categories 2A and 2B, they were sub-ranked by Composite Index. This led to them being grouped as in Table 5, below.

The Fund currently has enough pledges to pay for the first three groups. These have been labeled by GFO as "Immediately Approved: A, B and C". Proposals that fall into these three groups are approved, subject to satisfactory responses being provided to the TRP queries.

The Fund does not currently have sufficient pledges to pay for proposals in the next eight groups, labeled by GFO as "Provisionally Approved D, E, F, G, H, I, J and K". When the Fund received pledges sufficient to cover each additional group (in the order shown below), the board will approve those proposals by email.

The Secretariat will start working immediately with all provisionally approved applicants on dealing with TRP queries and negotiating grant agreements. If all those activities have been completed before pledges and actual cash contributions have been received, the actual signing of grant agreements will have to be put on hold.

However, provisionally approved proposals for which insufficient pledges are received by the end of June 2006 will lose their provisional approval and will be treated as if they had not been approved.

Table 5: Round 5 results by Category

Decision Explanation Number of proposals Budget

Years 1-2

 Budget

Years 1-5
Immediately Approved: A Category 1 5 $43,310,437 $98,935,651
Immediately Approved: B Category 2A, Composite Index 8 18 $290,762,706 $728,609,400
Immediately Approved: C Category 2A, Composite Index 6 3 $48,003,918 $149,563,776
Subtotal: All "Immediately Approved" proposals 26 $382,077,061 $977,108,827
Provisionally approved: D Category 2A, Composite Index 5 12 $133,276,403 $345,346,815
Provisionally approved: E Category 2A, Composite Index 4 2 $9,529,070 $24,888,718
Provisionally approved: F Category 2A, Composite Index 3 13 $92,575,047 $165,266,161
Provisionally approved: G Category 2B, Composite Index 8 4 $87,358,034 $207,352,569
Provisionally approved: H Category 2B, Composite Index 7 1 $3,269,731 $6,623,560
Provisionally approved: I Category 2B, Composite Index 6 1 $6,501,141 $21,232,348
Provisionally approved: J Category 2B, Composite Index 5 2 $3,356,219 $6,868,700
Provisionally approved: K Category 2B, Composite Index 3 2 $7,673,482 $19,814,848
Subtotal: All "Provisionally Approved" proposals 37 $343,539,127 $797,393,719
Total: All "Immediately Approved" plus "Provisionally Approved" proposals 63 $725,616,188 $1,774,502,546
Not approved: L Category 3 120 $2,266,242,296 $5,096,656,571
Not approved: M Category 4 19 $306,210,534 $750,510,205
Subtotal: All "Not Approved" proposals 139 $2,572,452,830 $5,847,166,776
GRAND TOTAL 202 $3,298,069,018 $7,621,669,322
Table 6: Round 5 results by country

Country

Applicant

Decision

(See definitions above)

Component

Budget Years 1-2

Budget Years 1-5
Afghanistan CCM Provisionally approved: D Malaria

$17,093,334

$32,214,069
Afghanistan CCM Not approved: L HIV/AIDS

$4,663,653

$10,953,024
Afghanistan CCM Not approved: L HSS

$1,980,090

$4,014,470
Albania CCM Provisionally approved: F HIV/AIDS

$2,502,858

$4,990,645
Albania CCM Provisionally approved: F TB

$877,685

$1,442,028
Angola CCM Not approved: L Malaria

$39,227,228

$115,827,277
Armenia CCM Provisionally approved: K TB

$3,898,656

$7,624,135
Armenia CCM Not approved: M Malaria

$1,705,100

$2,572,700
Azerbaijan CCM Immediately Approved: A TB

$3,825,770

$9,516,200
Azerbaijan CCM Not approved: L Malaria

$3,179,532

$7,255,952
Bangladesh CCM Immediately Approved: B TB

$10,003,984

$45,977,231
Bangladesh CCM Not approved: L HIV/AIDS

$8,135,641

$23,901,394
Bangladesh CCM Not approved: L Malaria

$18,478,606

$36,993,988
Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka Regional CM Not approved: M HIV/AIDS

$15,464,067

$59,842,897
Belarus CCM Not approved: L TB

$13,239,086

$26,389,516
Benin CCM Provisionally approved: D HIV/AIDS

$19,709,054

$51,841,972
Benin CCM Not approved: L HSS

$6,560,978

$12,130,576
Benin CCM Not approved: L Malaria

$10,714,920

$52,930,467
Benin CCM Not approved: L TB

$3,575,918

$7,793,321
Benin, Cote d'Ivoire, Ethiopia, Nigeria, Zimbabwe Regional org. (PSI and African Union) Not approved: M HIV/AIDS

$17,304,394

$44,804,606
Bosnia Herzegovina CCM Provisionally approved: F HIV/AIDS

$4,832,387

$11,042,257
Bosnia Herzegovina CCM Not approved: L TB

$1,171,290

$3,157,230
Botswana CCM Provisionally approved: E TB

$5,515,900

$8,956,258
Brazil CCM Immediately Approved: C TB

$11,602,427

$27,240,000
Burkina Faso CCM Not approved: L HIV/AIDS

$34,432,357

$71,569,383
Burkina Faso CCM Not approved: L HSS

$5,845,718

$9,170,885
Burkina Faso CCM Not approved: L Malaria

$19,208,881

$27,152,602
Burundi CCM Provisionally approved: G HIV/AIDS

$13,053,866

$32,353,173
Burundi CCM Not approved: L HSS

$2,370,296

$6,566,203
Burundi CCM Not approved: L Malaria

$12,215,162

$25,401,464
Cambodia CCM Immediately Approved: B TB

$3,268,750

$9,662,024
Cambodia CCM Provisionally approved: D HIV/AIDS

$16,292,779

$34,963,654
Cambodia CCM Provisionally approved: G HSS

$1,841,600

$5,015,741
Cambodia CCM Not approved: L Malaria

$5,854,119

$11,824,545
Cameroon CCM Immediately Approved: B HIV/AIDS

$4,943,590

$12,060,019
Cameroon CCM Immediately Approved: B Malaria

$12,695,885

$21,210,595
Cape Verde CCM Not approved: L HIV/AIDS

$4,313,270

$11,659,200
Central African Republic CCM Not approved: L HIV/AIDS

$22,082,191

$36,632,357
Central African Republic CCM Not approved: L Malaria

$7,598,940

$11,990,390
Chad CCM Not approved: L Malaria

$17,335,833

$36,713,126
China CCM Immediately Approved: C TB

$17,814,000

$52,889,000
China CCM Provisionally approved: F HIV/AIDS

$12,544,128

$28,902,074
China CCM Provisionally approved: F Malaria

$20,096,149

$39,410,395
Colombia CCM Not approved: L HIV/AIDS

$13,338,388

$29,356,545
Comoros CCM Not approved: L Malaria

$4,110,188

$7,727,600
Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama Regional org. (Secretary of Social Integration of Central America - SSICA) Not approved: M HIV/AIDS

$13,859,280

$30,722,300
Cote d'Ivoire Non-CCM (CARE) Immediately Approved: B HIV/AIDS

$3,522,695

$3,522,695
Cote d'Ivoire CCM Not approved: L HIV/AIDS

$26,836,531

$47,022,390
Cote d'Ivoire CCM Not approved: L Malaria

$7,897,631

$20,272,415
Dem. Rep. Congo CCM Immediately Approved: B TB

$17,613,606

$43,716,984
Dem. Rep. Congo CCM Not approved: L HIV/AIDS

$60,848,374

$142,154,402
Dem. Rep. Congo CCM Not approved: L HSS

$17,947,453

$40,244,494
Dem. Rep. Congo CCM Not approved: L Malaria

$21,184,713

$38,608,576
Dem. Rep. Congo - Kasai Sub-CCM Not approved: M HIV/AIDS

$66,831,110

$127,046,138
Dem. Rep. Congo - Kasai Sub-CCM Not approved: M Malaria

$16,564,000

$29,779,000
Dem. Rep. Congo - Kasai Sub-CCM Not approved: M TB

$12,702,000

$23,507,000
Djibouti CCM Not approved: L Malaria

$2,344,000

$5,113,000
Djibouti CCM Not approved: L TB

$4,819,773

$10,704,374
Dominican Republic CCM Not approved: L Malaria

$5,368,399

$11,914,220
East Timor CCM Provisionally approved: D HIV/AIDS

$4,304,454

$9,110,302
Ecuador CCM Not approved: L Malaria

$4,097,749

$4,097,749
Egypt CCM Not approved: L HIV/AIDS

$2,185,934

$6,201,772
Egypt CCM Not approved: L TB

$4,588,252

$11,085,278
Egypt CCM Not approved: M Malaria

$2,380,000

$5,000,000
El Salvador CCM Not approved: L Malaria

$1,100,000

$3,000,000
Equatorial Guinea CCM Not approved: L Malaria

$12,906,111

$25,999,072
Eritrea CCM Provisionally approved: D HIV/AIDS

$13,139,010

$33,892,005
Eritrea CCM Not approved: L HSS

$7,697,965

$14,435,485
Eritrea CCM Not approved: L Malaria

$8,844,992

$17,200,208
Eritrea CCM Not approved: L TB

$1,443,404

$3,879,324
Ethiopia CCM Provisionally approved: G Malaria

$64,548,913

$150,066,528
Ethiopia CCM Not approved: L HIV/AIDS

$23,145,990

$64,497,352
Ethiopia CCM Not approved: L HSS

$159,999,343

$348,014,355
Ethiopia CCM Not approved: L TB

$16,440,576

$69,882,371
Gabon CCM Provisionally approved: E Malaria

$4,013,170

$15,932,460
Georgia CCM Not approved: L HIV/AIDS

$2,797,640

$4,654,240
Georgia CCM Not approved: L HSS

$436,320

$814,320
Ghana CCM Immediately Approved: A TB

$14,547,546

$31,471,844
Ghana CCM Provisionally approved: D HIV/AIDS

$31,630,830

$97,099,610
Ghana CCM Not approved: L HSS

$12,552,761

$19,359,341
Ghana, Uganda, Zimbabwe Regional org. (TEPHINET) Not approved: M HSS

$16,363,767

$36,318,213
Guatemala CCM Not approved: L TB

$5,826,331

$11,623,999
Guinea CCM Immediately Approved: A TB

$3,391,501

$6,225,144
Guinea CCM Not approved: L Malaria

$3,467,563

$18,987,568
Haiti CCM Immediately Approved: B HIV/AIDS

$19,205,567

$49,927,069
India CCM Not approved: L Malaria

$14,742,454

$26,448,410
India CCM Not approved: L TB

$7,410,000

$25,020,000
India CCM Not approved: M HIV/AIDS

$67,620,403

$217,625,981
Indonesia CCM Immediately Approved: C TB

$18,587,491

$69,434,776
Indonesia CCM Not approved: L HIV/AIDS

$13,671,879

$26,117,640
Indonesia CCM Not approved: L Malaria

$43,145,932

$66,543,849
Iran CCM Not approved: L Malaria

$8,500,000

$18,600,000
Jordan CCM Provisionally approved: F TB

$1,072,864

$2,782,864
Jordan CCM Not approved: L HIV/AIDS

$3,588,958

$6,899,718
Kazakhstan CCM Not approved: L HIV/AIDS

$2,000,295

$4,814,539
Kazakhstan CCM Not approved: L TB

$8,375,651

$17,558,542
Kenya CCM Provisionally approved: G TB

$7,913,655

$19,917,127
Kenya CCM Not approved: L HIV/AIDS

$8,893,681

$19,796,832
Kenya CCM Not approved: L HSS

$11,179,083

$28,076,553
Kenya CCM Not approved: L Malaria

$4,230,600

$8,427,600
Kosovo CCM Not approved: L HIV/AIDS

$1,701,158

$3,687,350
Kyrgyzstan CCM Provisionally approved: D Malaria

$1,692,390

$3,426,125
Kyrgyzstan CCM Not approved: L TB

$5,309,127

$8,863,698
Lesotho CCM Immediately Approved: B HIV/AIDS

$10,013,383

$40,346,059
Liberia CCM Not approved: L HIV/AIDS

$12,394,177

$25,714,627
Liberia CCM Not approved: L HSS

$14,078,615

$17,374,573
Liberia CCM Not approved: L Malaria

$15,015,748

$33,165,706
Liberia CCM Not approved: L TB

$4,750,966

$11,949,773
Macedonia CCM Provisionally approved: F TB

$1,442,489

$3,071,097
Madagascar CCM Not approved: L HIV/AIDS

$9,512,412

$24,957,422
Madagascar CCM Not approved: L HSS

$4,965,759

$22,599,312
Madagascar CCM Not approved: L Malaria

$7,974,500

$33,470,801
Madagascar CCM Not approved: L TB

$8,900,519

$15,249,703
Malawi CCM Immediately Approved: B HIV/AIDS

$7,770,655

$19,104,775
Malawi CCM Immediately Approved: B HSS

$26,965,524

$65,429,986
Maldives CCM Not approved: M HIV/AIDS

$2,016,601

$4,184,665
Mali CCM Not approved: L HSS

$7,083,766

$11,600,785
Mali CCM Not approved: L Malaria

$14,862,149

$36,069,482
Mauritania CCM Provisionally approved: D HIV/AIDS

$6,584,973

$15,755,931
Mongolia CCM Provisionally approved: D HIV/AIDS

$1,898,775

$4,235,640
Montenegro CCM Provisionally approved: F HIV/AIDS

$1,604,606

$2,924,696
Mozambique CCM Not approved: L HSS

$72,100,000

$106,600,000
Mozambique CCM Not approved: L Malaria

$32,694,480

$73,121,487
Mozambique, South Africa, Swaziland Regional CM Provisionally approved: I Malaria

$6,501,141

$21,232,348
Namibia CCM Immediately Approved: A TB

$7,222,753

$17,777,383
Namibia CCM Not approved: L HIV/AIDS

$31,341,874

$91,950,544
Namibia CCM Not approved: L Malaria

$13,136,240

$21,897,490
Nepal CCM Not approved: L HIV/AIDS

$7,717,233

$25,788,007
Nepal CCM Not approved: L Malaria

$5,352,822

$11,372,370
Nepal CCM Not approved: L TB

$3,858,926

$9,481,273
Niger CCM Immediately Approved: B Malaria

$5,148,600

$10,491,196
Niger CCM Provisionally approved: D TB

$6,326,070

$12,220,815
Niger CCM Not approved: L HSS

$7,529,467

$11,474,188
Nigeria CCM Immediately Approved: B HIV/AIDS

$46,424,283

$180,642,512
Nigeria CCM Immediately Approved: B TB

$19,217,311

$53,351,149
Nigeria CCM Not approved: L HSS

$39,505,341

$64,812,236
Nigeria CCM Not approved: L Malaria

$52,404,797

$179,995,004
Pakistan CCM Not approved: L HIV/AIDS

$13,000,477

$34,989,566
Pakistan CCM Not approved: L Malaria

$11,293,294

$27,059,519
Pakistan CCM Not approved: L TB

$15,854,040

$30,308,701
Pakistan CCM Not approved: M HSS

$9,977,880

$26,617,490
Papua New Guinea CCM Not approved: L TB

$1,975,954

$10,784,888
Paraguay CCM Not approved: M HIV/AIDS

$3,941,134

$9,429,262
Peru CCM Provisionally approved: F HIV/AIDS

$9,874,896

$12,967,865
Peru CCM Provisionally approved: F TB

$21,017,537

$32,545,545
Peru CCM Not approved: L HSS

$6,894,200

$17,011,200
Philippines CCM Provisionally approved: F HIV/AIDS

$3,011,919

$6,478,058
Philippines CCM Provisionally approved: F Malaria

$11,097,529

$14,308,637
Philippines CCM Not approved: L TB

$14,208,812

$45,817,584
Republic of Congo CCM Provisionally approved: D HIV/AIDS

$12,043,407

$45,553,763
Republic of Congo CCM Not approved: L Malaria

$17,664,123

$28,331,791
Republic of Congo CCM Not approved: L TB

$4,669,340

$8,138,467
Russian Federation Non-CCM Provisionally approved: K HIV/AIDS

$3,774,826

$12,190,713
Rwanda CCM Immediately Approved: A HSS

$14,322,867

$33,945,080
Rwanda CCM Immediately Approved: B Malaria

$28,140,772

$39,649,363
Rwanda CCM Not approved: L HIV/AIDS

$36,053,491

$88,300,796
Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu Regional Coordinating Mechanism Not approved: L HIV/AIDS

$4,251,406

$9,946,332
Samoa, Cook Islands, Fiji, Kiribati, Marshall Islands, Micronesia, Nauru, Niue, Palau, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu Regional Coordinating Mechanism Not approved: L TB

$1,466,940

$4,432,060
Sao Tome & Principe CCM Provisionally approved: J HIV/AIDS

$584,218

$1,485,190
Senegal CCM Not approved: L TB

$8,725,379

$18,336,573
Senegal CCM Not approved: M HSS

$2,321,013

$3,384,233
Senegal CCM Not approved: M Malaria

$8,251,057

$12,117,141
Serbia CCM Not approved: L HIV/AIDS

$4,755,306

$8,462,528
Solomon Islands, Vanuatu Regional Coordinating Mechanism Provisionally approved: H Malaria

$3,269,731

$6,623,560
Somalia Non-CCM Not approved: L HSS

$1,175,365

$2,832,730
Somalia Non-CCM Not approved: L Malaria

$2,567,445

$14,532,272
South Africa CCM Not approved: L HIV/AIDS

$45,010,000

$108,289,000
South Africa CCM Not approved: L HSS

$21,851,000

$42,173,000
Sri Lanka CCM Not approved: L Malaria

$4,356,374

$7,290,124
Sri Lanka CCM Not approved: L TB

$1,700,680

$4,414,795
Sri Lanka CCM Not approved: M HIV/AIDS

$2,607,594

$5,357,285
Sudan CCM Not approved: L HIV/AIDS

$29,424,335

$112,553,275
Sudan CCM Not approved: L Malaria

$24,019,599

$46,323,995
Sudan CCM Not approved: L TB

$6,830,013

$15,410,468
Sudan CCM Not approved: M HSS

$42,800,000

$105,860,000
Sudan (Southern Sector) Sub-CCM Immediately Approved: B TB

$8,592,197

$27,568,526
Sudan (Southern Sector) Sub-CCM Not approved: L HSS

$25,929,249

$68,455,557
Suriname CCM Provisionally approved: F HIV/AIDS

$2,600,000

$4,400,000
Tajikistan CCM Provisionally approved: J Malaria

$2,772,001

$5,383,510
Tanzania CCM Not approved: L HIV/AIDS

$9,204,276

$11,932,883
Tanzania CCM Not approved: L HSS

$22,869,642

$34,866,750
Tanzania Zanzibar CCM Not approved: L HIV/AIDS

$12,722,287

$30,817,709
Thailand CCM Not approved: L HIV/AIDS

$5,920,079

$16,886,287
The Gambia CCM Provisionally approved: D TB

$2,561,327

$5,032,929
The Gambia CCM Not approved: L HIV/AIDS

$7,842,275

$14,733,869
The Gambia CCM Not approved: L Malaria

$18,169,122

$40,473,141
Tunisia CCM Not approved: L HIV/AIDS

$10,007,400

$20,898,000
Turkey CCM Not approved: M Malaria

$2,387,990

$4,784,490
Turkey CCM Not approved: M TB

$1,113,144

$1,556,804
Uganda CCM Not approved: L HIV/AIDS

$5,857,397

$17,746,651
Uganda CCM Not approved: L HSS

$5,605,994

$10,942,316
Uganda CCM Not approved: L Malaria

$49,494,235

$90,219,700
Vietnam CCM Not approved: L HIV/AIDS

$6,500,000

$20,000,000
Vietnam CCM Not approved: L TB

$7,037,112

$18,718,344
Yemen CCM Not approved: L Malaria

$15,889,956

$41,763,366
Zambia CCM Not approved: L HIV/AIDS

$481,308,000

$1,033,420,000
Zambia CCM Not approved: L HSS

$11,042,000

$34,940,000
Zambia CCM Not approved: L Malaria

$22,147,000

$41,200,000
Zambia CCM Not approved: L TB

$98,610,000

$246,525,000
Zimbabwe CCM Immediately Approved: B HIV/AIDS

$35,931,159

$62,478,891
Zimbabwe CCM Immediately Approved: B Malaria

$21,217,469

$29,998,400
Zimbabwe CCM Immediately Approved: B TB

$10,087,276

$13,471,926

Information on Round 5 grants is also available on the Global Fund web site at www.theglobalfund.org/en/about/board/eleventh.

An applicant may appeal the board's decision if the applicant submitted an eligible proposal for a particular component in both Round 4 and Round 5 and was not approved in either case. The appeal must show that the recommendation made by the TRP regarding the Round 5 proposal was based on a "significant and obvious" error. The appeal must be filed with the Secretariat no later than 28 days from when the applicant receives written notice of the board's Round 5 decision. For further details regarding the appeals procedure, see www.theglobalfund.org/en/apply/proposals/appeals.

Publication Date: 2005-10-03

Tags:

Leave a Comment
ABSTRACT A detailed listing and analysis is provided of which Round 5 proposals have been approved.

">
Comments

No comments yet. Be the first to comment!

Rate this article:
★ ★ ★ ★ ★

0 Ratings

Archives

View Archives

Other Articles from This Issue

Article Number: 1

GLOBAL FUND APPROVES FIFTH ROUND OF GRANTS

2005-10-03

Article Number: 2

MAIN DECISIONS MADE AT GLOBAL FUND BOARD MEETING

2005-10-03

FACEBOOK